A computational biology company that started in space tech is looking to change how biopharma finds disease targets by modeling how proteins behave.

For decades, scientists assumed that order drives efficiency. Yet in the bustling machinery of mitochondria—the organelles ...

Key opportunities in the protein labeling market include increasing demand for site-specific tags in proteomics and drug development, the rise of AI tools for protein structure prediction, and the ...

Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: ...

One of the hallmarks of Alzheimer’s disease is the clumping of proteins called Tau, which form tangled fibrils in the brain. The more severe the clumping, the more advanced the disease is. The Tau ...

Researchers found that paired pathogenic variants can restore protein function rather than make it worse. This phenomenon ...

Blood flows around the body through a complex network of vessels, which must constantly adapt to changing needs. The balance ...

A new preclinical study has shown that reducing the protein HDAC11 could slow muscle degeneration in Duchenne muscular dystrophy, providing a potential target for future therapies.

An experimental inhibitor regrew cartilage in aged mice, opening up an alternative to arthritis and prosthetics.

We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at ...

Every time a cell divides, it must copy its entire genome so that each daughter cell inherits a complete set of DNA. During that process, enzymes known as polymerases race along the DNA to copy its ...